PuSH - Publication Server of Helmholtz Zentrum München: Label-free single-cell phenotyping to determine tumor cell heterogeneity in pancreatic cancer in real time.

Navigation

Home

Deutsch

Research

Advanced Search

Browse by ...

... Journal

... Publication Type

... Research Data

... Publication Year

Publication overview

Support & Contact

Contact persons

Help

Data protection

Wittenzellner, K.* ; Lengl, M.* ; Röhrl, S.* ; Maurer, C.* ; Klenk, C.* ; Papargyriou, A. ; Schmidleitner, L.* ; Kabella, N.* ; Shastri, A.R.* ; Fresacher, D.E.* ; Harb, F.* ; Hafez, N.* ; Bärthel, S.* ; Lucarelli, D.* ; Escorial-Iriarte, C.* ; Orben, F.* ; Öllinger, R.* ; Emken, E.* ; Fricke, L.* ; Madej, J.* ; Wustrow, P.* ; Ekin Demir, I.* ; Friess, H.* ; Lahmer, T.* ; Schmid, R.M.* ; Rad, R.* ; Schneider, G.* ; Kuster, B.* ; Saur, D.* ; Hayden, O.* ; Diepold, K.* ; Reichert, M.

Label-free single-cell phenotyping to determine tumor cell heterogeneity in pancreatic cancer in real time.

JCI insight 10:e169105 (2025)

Publ. Version/Full Text

Research data

DOI

	Open Access Gold

Abstract
Metrics
Extra information

Resistance to chemotherapy of pancreatic ductal adenocarcinoma (PDAC) is largely driven by intratumoral heterogeneity (ITH) due to tumor cell plasticity and clonal diversity. To develop alternative strategies to overcome this defined mechanism of resistance, tools to monitor and quantify ITH in a rapid and scalable fashion are needed urgently. Here, we employed label-free digital holographic microscopy (DHM) to characterize ITH in PDAC. We established a robust experimental and machine learning analysis pipeline to perform single-cell phenotyping based on DHM-derived phase images of PDAC cells in suspension. Importantly, we were able to detect dynamic changes in tumor cell differentiation and heterogeneity of distinct PDAC subtypes upon induction of epithelial-mesenchymal transition and under treatment-imposed pressure in murine and patient-derived model systems. This platform allowed us to assess phenotypic ITH in PDAC on a single-cell level in real time. Implementing this technology into the clinical workflow has the potential to fundamentally increase our understanding of tumor heterogeneity during evolution and treatment response.

Altmetric

Additional Metrics?

[➜Log in]

Edit extra informations Login

Publication type Article: Journal article

Document type Scientific Article

Corresponding Author

Keywords Ductal Adenocarcinoma; Subtypes; Survival

ISSN (print) / ISBN 2379-3708

e-ISSN 2379-3708

Journal JCI insight

Quellenangaben Volume: 10, Issue: 13, Article Number: e169105

Publisher Clarivate

Publishing Place Ann Arbor, Michigan

Non-patent literature Publications

Reviewing status Peer reviewed

Institute(s) Institute of Stem Cell Research (ISF)

Grants BZKF Lighthouse Project: "Preclinical Model Systems"
Deutsche Krebshilfe
Wilhelm Sander Stiftung
German Cancer Aid
Bavarian Ministry of Economic Affairs, Regional Development and Energy
Project EISglobe
Federal Ministry of Education and Research
QuE-MRT
FAIRPACT
DKTK Strategic Initiative Organoid Platform
DFG